Comparative Effectiveness of Guidelines for the Management of Hyperlipidemia and Hypertension for Type 2 Diabetes Patients
2011

Comparative Effectiveness of Guidelines for Managing Hyperlipidemia and Hypertension in Type 2 Diabetes Patients

Sample size: 663 publication Evidence: moderate

Author Information

Author(s): Shah Nilay D., Mason Jennifer, Kurt Murat, Denton Brian T., Schaefer Andrew J., Montori Victor M., Smith Steven A.

Primary Institution: Mayo Clinic

Hypothesis

The efficiency and effectiveness of international guidelines for managing hypertension and hyperlipidemia in type 2 diabetes patients are unclear.

Conclusion

International guidelines are similar in effectiveness but differ significantly in expected medication costs.

Supporting Evidence

  • All guidelines are equally effective in preventing cardiovascular events.
  • Medication costs vary significantly across different guidelines.
  • The Australian guidelines have the highest expected medication costs.
  • The US guidelines are generally more efficient compared to other published guidelines.
  • Incremental changes in guidelines did not significantly impact absolute risk for primary prevention.

Takeaway

Different countries have guidelines for treating diabetes, but they all work about the same; however, some are much more expensive than others.

Methodology

A Markov model was used to compare the efficiency and effectiveness of guidelines for managing hypertension and hyperlipidemia in type 2 diabetes patients aged 40-80.

Potential Biases

Potential conflicts of interest in guideline formulation may influence recommendations.

Limitations

The model is based on point estimates and does not consider medication adverse effects, non-adherence, or discontinuation.

Participant Demographics

Caucasian, non-smoking patients aged 40-80 with type 2 diabetes.

Digital Object Identifier (DOI)

10.1371/journal.pone.0016170

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication